Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare

Por Hendrikx, Jos, Fransen, Jaap, van Riel, Piet L C M
Publicado no RMD Open (2015)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals

Por Popa, Calin D., Arts, Elke, Fransen, Jaap, van Riel, Piet L. C. M.
Publicado em 2012

What does the clinician need to improve patient care in systemic sclerosis?

Por Vonk, Madelon C, van den Hoogen, Frank H J, van Riel, Piet L C M, Valentini, Gabriele
Publicado em 2007

Biosimilars in the management of chronic inflammatory diseases: The Dutch experience

Por Wieland D. Müskens, Rongen-van Dartel Sanne A. A., Eddy M. M. Adang, van Riel Piet L. C. M.
Publicado em 2019-01-01

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

Por Crowson, Cynthia S., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M., Gabriel, Sherine E., Semb, Anne Grete
Publicado no PLoS One (2017)

Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

Por Crowson, Cynthia S., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M., Gabriel, Sherine E., Semb, Anne Grete
Publicado no PLoS One (2017)

Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response

Por HAAGSMA, CEES J, RUSSEL, FRANS G M, VREE, TOM B, VAN RIEL, PIET L C M, VAN DE PUTTE, LEVINUS B A
Publicado em 1996

Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti‐tumour necrosis factor treatment

Por Klooster, Peter M ten, Veehof, Martine M, Taal, Erik, van Riel, Piet L C M, van de Laar, Mart A F J
Publicado em 2007

The relationship between change in subjective outcome and change in disease: a potential paradox

Por Kievit, Wietske, Hendrikx, Jos, Stalmeier, Peep F. M., van de Laar, Mart A. F. J., Van Riel, Piet L. C. M., Adang, Eddy M.
Publicado em 2010

A Replication Study of the Association between Rheumatoid Arthritis and Deletion of the Late Cornified Envelope Genes LCE3B and LCE3C

Por Bergboer, Judith G. M., Umićević-Mirkov, Maša, Fransen, Jaap, den Heijer, Martin, Franke, Barbara, van Riel, Piet L. C. M., Schalkwijk, Joost, Coenen, Marieke J. H.
Publicado em 2012

Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry

Por Steunebrink, Laura M. M., Vonkeman, Harald E., ten Klooster, Peter M., Hoekstra, Monique, van Riel, Piet L. C. M., van de Laar, Mart A. F. J.
Publicado no Clin Rheumatol (2016)

Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis

Por van Lieshout, Antoine W T, Fransen, Jaap, Flendrie, Marcel, Eijsbouts, Agnes M M, van den Hoogen, Frank H J, van Riel, Piet L C M, Radstake, Timothy R D J
Publicado em 2007

Psychophysiological Responses to Stress after Stress Management Training in Patients with Rheumatoid Arthritis

Por de Brouwer, Sabine J. M., Kraaimaat, Floris W., Sweep, Fred C. G. J., Donders, Rogier T., Eijsbouts, Agnes, van Koulil, Saskia, van Riel, Piet L. C. M., Evers, Andrea W. M.
Publicado em 2011

Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor α‐neutralising treatments in rheumatoid art...

Por Radstake, Timothy R D J, Fransen, Jaap, Toonen, Erik J M, Coenen, Marieke J H, Eijsbouts, Agnes E, Donn, Rachelle, van den Hoogen, Frank H J, van Riel, Piet L C M
Publicado em 2007

Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis

Por ten Klooster, Peter M, Vonkeman, Harald E, Taal, Erik, Siemons, Liseth, Hendriks, Lidy, de Jong, Alphons J L, Dutmer, Ellen A J, van Riel, Piet L C M, van de Laar, Mart A F J
Publicado em 2013

The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis

Por van den Bemt, Bart J F, den Broeder, Alfons A, Wolbink, Gert-Jan, van den Maas, Aatke, Hekster, Yechiel A, van Riel, Piet L C M, Benraad, H Bart, van den Hoogen, Frank H J
Publicado em 2013

Serum Samples That Have Been Stored Long-Term (>10 Years) Can Be Used as a Suitable Data Source for Developing Cardiovascular Risk Prediction Models in Large Observational Rheumato...

Por Arts, Elke E. A., Popa, Calin D., Smith, Jacqueline P., Arntz, Onno J., van de Loo, Fons A., Donders, Rogier, Semb, Anne Grete P., Kitas, George D., van Riel, Piet L. C. M., Fransen, Jaap
Publicado em 2014

Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry

Por Manders, Sofie H M, van de Laar, Mart A F J, Rongen-van Dartel, Sanne A A, Bos, Reinhard, Visser, Henk, Brus, Herman L, Jansen, Tim, Vonkeman, Harald E, van Riel, Piet L C M, Kievit, Wietske
Publicado no RMD Open (2015)

Modulation of lipoprotein plasma concentrations during long‐term anti‐TNF therapy in patients with active rheumatoid arthritis

Por Popa, Calin, van den Hoogen, Frank H J, Radstake, Timothy R D J, Netea, Mihai G, Eijsbouts, Agnes E, den Heijer, Martin, van der Meer, Jos W M, van Riel, Piet L C M, Stalenhoef, Anton F H, Barrera, Pilar
Publicado em 2007

Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis

Por Toonen, Erik J. M., Gilissen, Christian, Franke, Barbara, Kievit, Wietske, Eijsbouts, Agnes M., den Broeder, Alfons A., van Reijmersdal, Simon V., Veltman, Joris A., Scheffer, Hans, Radstake, Timothy R. D. J., van Riel, Piet L. C. M., Barrera, Pilar, Coenen, Marieke J. H.
Publicado em 2012